Thyroid toxicity as predictor of response to immunotherapy in lung cancer

被引：0
|
作者：
Kazanietz, V. [1 ]
Cayol, F. [1 ]
Cerini, M. [1 ]
Storino, J. [1 ]
Specterman, S. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Oncol, Buenos Aires, DF, Argentina
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1066P
引用
收藏
页码：S725 / S725
页数：1
相关论文
共 50 条
  • [1] Sex as a predictor of response to cancer immunotherapy
    Kwon, Hyunwoo
    Lin, Ching Ying
    Chung, Dongjun
    Li, Xue
    Li, Zihai
    LANCET ONCOLOGY, 2018, 19 (08): : E379 - E379
  • [2] Analysis of Patient Microbiome and Its Correlation to Immunotherapy Response and Toxicity in Lung Cancer
    Chau, J.
    Yadav, M.
    Furqan, M.
    Cady, N.
    Mercer, K. Nace
    Eastman, E.
    Abu-Hejleh, T.
    Shahi, S.
    Dai, Q.
    Zakharia, Y.
    Garje, R.
    Chan, C.
    Weiner, G.
    Mangalam, A.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1132 - S1132
  • [3] Analysis of Patient Microbiome and Its Correlation to Immunotherapy Response and Toxicity in Lung Cancer
    Chau, J.
    Yadav, M.
    Furqan, M.
    Cady, N.
    Mercer, K.
    Eastman, E.
    Abu-Hejleh, T.
    Clamon, G.
    Shahi, S.
    Dai, Q.
    Zakharia, Y.
    Garje, R.
    Chan, C.
    Weiner, G.
    Mangalam, A.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S715 - S715
  • [4] Sex as a predictor of response to cancer immunotherapy Reply
    Conforti, Fabio
    Pala, Laura
    Bagnardi, Vincenzo
    De Pas, Tommaso
    Marco, Martinetti
    Viale, Giuseppe
    Gelber, Richard
    Goldhirsch, Aron
    LANCET ONCOLOGY, 2018, 19 (08): : E380 - E381
  • [5] Endocrine toxicity as an independent predictor of response to immune checkpoint inhibitors in lung cancer patients
    Charpidou, Andriani
    Panagiotou, Emmanouil
    Ntouraki, Sofia
    Vathiotis, Ioannis A.
    Livanou, Maria Effrosyni
    Trimis, Athanasios
    Syrigos, Konstantinos
    Peppa, Melpomeni
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [6] Immune-related adverse events (IrAEs) as a predictor of response to immunotherapy in patients with lung cancer
    Sanchez Becerra, M. V.
    Martinez-Cabanes, R.
    Gonzalez-Lopez, A.
    Zhan-Zhou, E.
    Sotelo, V.
    Esteban, M.
    Robles, T.
    Camara, J. C.
    Cardena, A.
    Hernando, S.
    Hurtado, A.
    Moreno, D.
    Olier, C.
    Mielgo Rubio, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S808 - S809
  • [7] Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)
    Nguyen, J.
    Quere, G.
    Descourt, R.
    Geier, M.
    Babey, H.
    Saliou, P.
    Picard, J.
    Dhamelincourt, E.
    Fave, T.
    Laune, Q.
    Simaki, A.
    Renaud, E.
    Cornec, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S618 - S618
  • [8] Metabolic Characteristics of Non-Small Cell Lung Cancer Lesions as Potential Predictor of Immunotherapy Response
    Tabain, A.
    Rogan, S. A.
    Divosevic, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S67 - S67
  • [9] Exploring the role of TIGIT in patients with Small Cell Lung Cancer as a novel predictor of prognosis and immunotherapy response
    Liu, Li
    Wu, Peng
    Wang, Bingzhi
    Dong, Jiyan
    Zhang, Chaoqi
    Liu, Wenchao
    Ying, Jianming
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [10] Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
    Kollipara, Revathi
    Schneider, Bryan
    Radovich, Milan
    Babu, Sunil
    Kiel, Patrick J.
    ONCOLOGIST, 2017, 22 (10): : 1149 - 1151
12345